Advertisement
Organisation › Details
Octapharma AG (CH)
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein product manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell lines. Octapharma’s revenue forecast for 2015 is EUR 1.5 billion. Octapharma has 48 subsidiaries and representative offices and employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the following therapeutic areas: Haematology (coagulation disorders) Immunotherapy (immune disorders) Critical Care Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico. *
Start | 1983-01-01 established | |
Group | Octapharma (Group) | |
Industry | BLOOD PRODUCTS | |
Person | Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder) | |
Region | Lachen SZ | |
Country | Switzerland | |
Street | 2 Seidenstr. | |
City | 8853 Lachen SZ | |
Tel | +41-55-451-2121 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | G: 5,001 to 10,000 (2012-12-31) |
Currency | EUR | |
Annual sales | 1,500,000,000 (revenue, forecast (2015) 2015-12-31) | |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top